Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04554706 · ClinicalTrials.gov registry record · NA

Evaluating a Mobile Phone Intervention

A NA study, sponsored by University of Southern California.

Completed
Registry status
NA
Development phase
150
Enrollment target

NCT04554706: Completed NA study, sponsored by University of Southern California.

NCT04554706 is a NA study that has completed, run by University of Southern California. The registered enrollment target is 150 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04554706, a NA study, has completed, sponsored by University of Southern California.

COMPLETED
Registry status
NA
Development phase
150 participants
Enrollment target

Study Summary

This clinical trial intends to study the efficacy of a mobile phone delivered intervention in reducing depression-related rumination.

Primary Outcome

Momentary Ruminative Self-Focus Inventory-Abbreviated (MRSI-A). The MRSI is a 6-item questionnaire measuring state-level fluctuations in ruminative self-focus. Each item ranges from 1 (Strongly disagree) to 7 (Strongly agree).

Interventions

  • BEHAVIORAL Mobile-phone delivered Treatment for Excessive Rumination

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2021-05-06
Est. Completion 2021-11-06
Phase NA
University of Southern California

617 total trials

What the finished NCT04554706 record still lists

NCT04554706 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).

The record links to 0 conditions, and to 1 intervention - of which Mobile-phone delivered Treatment for Excessive Rumination is the first listed.

NCT04554706 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04554706 about?

NCT04554706 is a clinical study titled "Evaluating a Mobile Phone Intervention". This clinical trial intends to study the efficacy of a mobile phone delivered intervention in reducing depression-related rumination.

What is the current status of trial NCT04554706?

This trial is currently completed. It is a NA study. The enrollment target is 150 participants. The study started on 2021-05-06. Estimated completion is 2021-11-06.

What interventions are being tested in trial NCT04554706?

The interventions under investigation include: Mobile-phone delivered Treatment for Excessive Rumination (BEHAVIORAL).

Who is sponsoring clinical trial NCT04554706?

This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04554706's enrollment target sits among peer trials

150 661st of 2000 higher than 1,299 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00412594 · 150 participants · Phase 2

    Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia

  • NCT01484730 · 150 participants

    A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion

  • NCT01985919 · 150 participants

    Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples

  • NCT02016248 · 150 participants · NA

    SBRT Boost for Unfavorable Prostate Cancer'

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04554706, the US trial registry maintained by the National Library of Medicine. NCT04554706 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.